Skip to main content
SpringerLink
Log in

Opioid peptides and glucose metabolism

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cryer P.E. Glucose homeostasis and hypoglycemia. In: Wilson J.D., Foster D.W. (Eds.), Williams textbook of endocrinology. Saunders, Philadelphia, 1985, p. 989.

    Google Scholar 

  2. North R.A., Egan T.M. Action and distributions of opioid peptides in peripheral tissues. Br. Med. Bull. 39: 71, 1983.

    PubMed  CAS  Google Scholar 

  3. Smyth D.G. α-endorphin and related peptides in pituitary, brain, pancreas and antrum. Br. Med. Bull. 39: 25, 1983.

    PubMed  CAS  Google Scholar 

  4. Krieger D.T., Martin J.B. Brain peptides (first part). N. Engl. J. Med. 304: 876, 1981.

    Article  PubMed  CAS  Google Scholar 

  5. Hughes J. Biogenesis, release and inactivation of enkephalins and dynorphins. Br. Med. Bull. 39: 17, 1983.

    PubMed  CAS  Google Scholar 

  6. Thompson J.W. Opioid peptides. Br. Med. J. 288: 259, 1984.

    Article  CAS  Google Scholar 

  7. Paterson S.J., Robson L.E., Kosterlitz H.W. Classification of opioid receptors. Br. Med. Bull. 39: 31, 1983.

    PubMed  CAS  Google Scholar 

  8. Feldberg W., Pyke D.A., Stubbs W.A. Hyperglycaemia: imitating Claude Bernard’s piqure with drugs. J. Autonom. Ner. Syst. (in press).

  9. Feldberg W.S., Shaligram S.V. The hyperglycaemic effect of morphine. Br. J. Pharmacol. 46: 602, 1972.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  10. Van Loon G.R., Appel N.M. β-endorphin-induced increases in plasma dopamine, norepinephrine and epinephrine. Res. Commun. Chem. Pathol. Pharmacol. 27: 607, 1980.

    PubMed  Google Scholar 

  11. Van Loon G.R., Appel N.M. β-endorphin-induced hyperglycaemia is mediated by increased central sympathetic outflow to adrenal medulla. Brain Res. 204: 236, 1981.

    Article  PubMed  Google Scholar 

  12. Iguchi A., Matsunaga H., Nomura T., Gotoh M., Sakamoto N. Glucoregulatory effects of intrahypothalamic injections of bombesin and other peptides. Endocrinology 114: 2242, 1984.

    Article  PubMed  CAS  Google Scholar 

  13. Helman A.M., Giraud P., Nicolaidis S., Oliver C., Assan R. Glucagon release after stimulation of the lateral hypothalamic area in rats: predominant β-adrenergic transmission and involvement of endorphin pathways. Endocrinology 113: 1, 1983.

    Article  PubMed  CAS  Google Scholar 

  14. Feldberg W., Pyke D.A., Stubbs W.A. On the origin of non-insulin dependent diabetes. Lancet 1: 1263, 1985.

    Article  PubMed  CAS  Google Scholar 

  15. Feldberg W., Pyke D.A., Stubbs W.A. Hyperglycaemia, a morphine-like effect produced by naloxone in cat. J. Physiol. 340: 121, 1983.

    PubMed Central  PubMed  CAS  Google Scholar 

  16. Sawynok J., Pinsky C., LaBella F.S. Minireview on the specificity of naloxone as an opiate antagonist. Life Sci. 25: 1621, 1979.

    Article  PubMed  CAS  Google Scholar 

  17. Ipp E., Garberoglio C., Richter H., Moossa R.A., Rubenstein A.H. Naloxone decreases centrally induced hyperglycaemia in dogs. Evidence for an opioid role in glucose homeostasis. Diabetes 33: 619, 1984.

    Article  PubMed  CAS  Google Scholar 

  18. Matsumura M., Fukushima T., Saito H., Saito S. In vivo and in vitro effects of α-endorphin on glucose metabolism in the rat. Horm. Metab. Res. 16: 27, 1984.

    Article  PubMed  CAS  Google Scholar 

  19. Allan H.L., Green C., Titheradge A. The stimulation of glycogenolysis and gluconeogenesis in isolated hepatocytes by opioid peptides. Biochem. J. 216: 507, 1983.

    PubMed Central  PubMed  CAS  Google Scholar 

  20. Radosevich P.M., Williams P.E., Brooks-Lacy D., McRae J.R., Steiner K.E., Cherrington A.D., Lacy W.W., Abumrad N.N. Effects of morphine on glucose homeostasis in the conscious dog. J. Clin. Invest. 74: 1473, 1984.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  21. Radosevich P.M., Williams P.E., McRae J.R., Lacy W.W., Orth D.N., Abumrad N.N. β-endorphin inhibits glucose production in the conscious dog. J. Clin. Invest. 73: 1237, 1984.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  22. El-Tayeb K.M., Brubacker P.L., Vranic M., Lickley L.A. β-endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in normal dogs. Diabetes 34: 1293, 1985.

    Article  PubMed  CAS  Google Scholar 

  23. Werther G.A., Joffe S., Artal R., Sperling M.A. Opiate modulation of glucose turnover in dogs. Metabolism 34: 136, 1985.

    Article  PubMed  CAS  Google Scholar 

  24. Werther G.A., Joffe S., Artal R., Sperling M.A. Opiates modulate insulin action in vivo in dogs. Diabetologia 26: 65, 1984.

    Article  PubMed  CAS  Google Scholar 

  25. Ipp E., Dhorajiala J., Pugh W., Moossa A.R., Rubenstain A.H. Effects of an enkephalin analog on pancreatic endocrine function and glucose homeostasis in normal and diabetic dogs. Endocrinology 111: 2110, 1982.

    Article  PubMed  CAS  Google Scholar 

  26. Bruni J.F., Watkins W.B., Yen S.S.C. β-endorphin in the human pancreas. J. Clin. Endocrinol. Metab. 49: 649, 1979.

    Article  PubMed  CAS  Google Scholar 

  27. Grube D., Voigt K.H., Weber E. Pancreatic glucagon cells contain enkephalin-like immunoreactivity. Histochemistry 59: 75, 1978.

    Article  PubMed  CAS  Google Scholar 

  28. Forsmann W.G., Helmstaedter V., Feurle G. Relationship of enkephalin and endorphin immunoreactivity with D-cells and G-cells of stomach. Acta Hepatogastroenterol. 24: 488, 1977.

    Google Scholar 

  29. Ipp E., Dobbs R., Unger R.H. Morphine and α-endorphin influence the secretion of the endocrine pancreas. Nature 276: 190, 1978.

    Article  PubMed  CAS  Google Scholar 

  30. Hermansen K. Enkephalins and the secretion of pancreatic somatostatin and insulin in the dog: studies in vitro. Endocrinology 113: 1149, 1983.

    Article  PubMed  CAS  Google Scholar 

  31. Rudman D., Berry C.I., Riedburg C.H., Hollins B.M., Kutner M.H., Lynn M.J., Chawla R.K. Effects of opioid peptides and opiate alkaloids on insulin secretion in the rabbit. Endocrinolgy 112: 1702, 1983.

    Article  CAS  Google Scholar 

  32. Pierluissi R., Pierluissi J., Ashcroft S.J.K. Effects of an enkephalin analogue (DAMME) on insulin release from cultured rat islets of Langerhans. Diabetologia 20: 642, 1981.

    Article  PubMed  CAS  Google Scholar 

  33. Kanter R.A., Ensink. J.W., Fujimoto W.J. Disparate effects of enkephalin and morphine upon insulin and glucagon secretion by islet cell cultures. Diabetes 29: 84, 1980.

    Article  PubMed  CAS  Google Scholar 

  34. Green I.C., Perrin D., Pedley K.C., Leslie R.D.G., Pyke D. Effect of enkephalins and morphine on insulin secretion from isolated rat islets. Diabetologia 19: 158, 1980.

    Article  PubMed  CAS  Google Scholar 

  35. Sachse G., Laube H., Svedberg J., Breidenbach T., Teschemacher H. Opiates influence endocrine pancreas secretion. Diabetologia 21: 322, 1981 (Abstract).

    Google Scholar 

  36. Green I.E., Ray K., Perrin D. Opioid peptide effects on insulin release and c-AMP in islets of Langerhans. Horm. Metab. Res. 15: 124, 1983.

    Article  PubMed  CAS  Google Scholar 

  37. Ryder S., Gollapudi G.M., Ryder D. Morphine sulfate inhibits insulin release from isolated, superinfused rat pancreatic islets. Horm, Metab. Res. 12: 412, 1980.

    Article  CAS  Google Scholar 

  38. Green I.E., Perrin D., Penman E., Yaseen A., Ray K., Howel S.L. Effect of dynorphin on insulin and somatostatin secretion, calcium uptake, and c-AMP levels in isolated rat islets of Langerhans. Diabetes 32: 685, 1983.

    Article  PubMed  CAS  Google Scholar 

  39. Awoke S., Voyles N., Bhathena S.J., Taneneberg R.J., Recant L. Alterations of plasma opioid activity in human diabetics. Life Sci. 34: 1999, 1984.

    Article  PubMed  CAS  Google Scholar 

  40. Hart I.C., Cowie A.T. Effect of morphine, naloxone and an enkephalin analogue on plasma prolactin, growth hormone, insulin and thyroxine in goats. J. Endocrinol. 77: 16, 1978.

    Article  Google Scholar 

  41. Schusdziarra V., Specht J., Schick R., De la Fuente A., Holland A., Pfeiffer E.F. Effect of morphine, leu-enkephalin and β-casomorphins on basal somatostatin release in dogs. Horm. Metab. Res. 15: 407, 1983.

    Article  PubMed  CAS  Google Scholar 

  42. Schusdziarra V., Schick A., De la Fuente A., Specht J., Klier M., Brantl V., Pfeiffer E.V. Effect of β-casomorphins and analogs on insulin release in dogs. Endocrinology 112: 885, 1983.

    Article  PubMed  CAS  Google Scholar 

  43. Stubbs W.A., Jones A., Edwards C.R.W., Delitala G., Jeffcoate W.J., Ratter S.J., Besser G.M., Bloom S.R., Alberti K.G.M.M. Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet 2: 1225, 1978.

    Article  PubMed  CAS  Google Scholar 

  44. Jeanrenaud X., Maeder E., Del Pozo E., Felber J.P. Effect of an enkephalin analogue (FK 33-824) on glucose tolerance in man. Acta Endocrinol. (Kbh.) 104: 85, 1983.

    CAS  Google Scholar 

  45. Reid R.L., Yen S.S.C. β-endorphin stimulates the secretion of insulin and glucagon in humans. J. Clin. Endocrinol. Metab. 52: 592, 1981.

    Article  PubMed  CAS  Google Scholar 

  46. Feldman M., Kiser R.S., Unger R.H., Li C.H. β-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings. N. Engl. J. Med. 308: 349, 1983.

    Article  PubMed  CAS  Google Scholar 

  47. Reid R.L., Sandler J.A., Yen S.S.C. β-endorphin stimulates the secretion of insulin and glucagon in diabetes mellitus. Metabolism 23: 197, 1984.

    Article  Google Scholar 

  48. Morley J.E., Baranetsky N.G., Wingert T.D. Endocrine effects on naloxone-induced opiate receptor blockade. J. Clin. Endocrinol. Metab. 50: 251, 1980.

    Article  PubMed  CAS  Google Scholar 

  49. Giugliano D., Ceriello A., Di Pinto P., Saccomanno F., Gentile S., Cacciapuoti F. Impaired insulin secretion in human diabetes mellitus. The effect of naloxone-induced opiate receptor blockade. Diabetes 31: 367, 1982.

    Article  PubMed  CAS  Google Scholar 

  50. Serri O., Rasio E., Somma M. Effects of naloxone on insulin-induced release of pituitary hormones. J. Clin. Endocrinol, Metab. 53: 206, 1981.

    Article  CAS  Google Scholar 

  51. Wakabayashi I., Demura R., Miki N., Ohmura E., Miyoshi H., Shizume K. Failure of naloxone to influence plasma growth hormone, prolactin, and Cortisol secretions induced by insulin hypoglycaemia. J. Clin. Endocrinol. Metab. 50: 597, 1980.

    Article  PubMed  CAS  Google Scholar 

  52. Bright G.M., Kaiser D.L., Rogol A.D., Clarke W.L. Naloxone attenuates recovery from insulin-induced hypoglycaemia in normal man. J. Clin. Endocrinol. Metab. 57: 213, 1983.

    Article  PubMed  CAS  Google Scholar 

  53. Copolov D., Jethwa J., Stern A., Clements J., Funder J.W. Insulin hypoglycaemia and cholinergic blockade: response of plasma immunoreactive β-endorphin. Clin. Endocrinol. (Oxf.) 19: 575, 1983.

    Article  CAS  Google Scholar 

  54. Armistead J.G., Lightman S.L., Brown M.J., Causon R.C., Vaughan N.J.A. The effect of selective and non-selective β-adrenoreceptor blockade, and of naloxone infusion, on the hormonal mechanisms of recovery from insulin-induced hypolycaemia in man. Br. J. Clin. Pharmacol. 16: 718, 1983.

    Article  Google Scholar 

  55. Giugliano D., Ceriello A., Quatraro A., Paolisso G., Varano R., D’Onofrio F. Interaction between epinephrine, prostaglandin E, and metenkephalin in the regulation of insulin release in man. Diabete Metab. 11: 295, 1985.

    PubMed  CAS  Google Scholar 

  56. Passariello N., Giugliano D., Quatraro A., Consoli G., Sgambato S., Torella R., D’Onofrio F. Glucose tolerance and hormonal responses in heroin addicts. A possible role for endogenous opiates in the pathogenesis of non-insulin-dependent diabetes. Metabolism 23: 1163, 1983.

    Article  Google Scholar 

  57. Giugliano D. Morphine, opioid peptides, and pancreatic islet function. Diabetes Care 7: 92, 1984.

    Article  PubMed  CAS  Google Scholar 

  58. Morley J.E., Yamada T., Walsh J.H., Lamers C.B., Wong H., Shulkes A., Damassa D.A., Gordon J., Carlson H.E., Hershman J. Morphine addiction and withdrawal alters brain peptide concentrations. Life Sci. 26: 2239, 1980.

    Article  PubMed  CAS  Google Scholar 

  59. Leslie R.D.G., Pyke D.A., Stubbs W.A. Sensitivity to enkephalin as a cause of non-insulin dependent diabetes. Lancet 1: 341, 1979.

    Article  PubMed  CAS  Google Scholar 

  60. Johnston C., Wiles P.G., Medbak S., Bowcock S., Cooke E.D., Pyke D.A., Rees L.H. The role of endogenous opioids in the chlorpropamide alcohol flush. Clin. Endocrinol. (Oxf.) 21: 489, 1984.

    Article  CAS  Google Scholar 

  61. Recant L., Voyles N., Wade A., Awoke S., Bhathena S.J. Studies on the role of opiate peptides in two forms of genetic obesity: ob/ob mouse and fa/fa rat. Horm. Metab. Res. 15: 589, 1983.

    Article  PubMed  CAS  Google Scholar 

  62. Greenberg J., Ellyin F., Pullen G., Ehrenpreis S., Singh S.P., Cheng J. Methionine-enkephalin and α-endorphin levels in brain, pancreas and adrenals of db/db mice. Endocrinology 116: 328, 1985.

    Article  PubMed  CAS  Google Scholar 

  63. Garthwaite T.L., Martinson D.R., Tseng L.F., Hagen T.C., Menahan L.A. A longitudinal hormonal profile of the genetically obese mouse. Endocrinology 107: 671, 1980.

    Article  PubMed  CAS  Google Scholar 

  64. Ono T., Oomura Y., Nishino H., Sasaki K., Muramoto K., Yano I. Morphine and enkephalin effects on hypothalamic glucoresponsive neurons. Brain Res. 185: 208, 1980.

    Article  PubMed  CAS  Google Scholar 

  65. Matsumura M., Yamanoi A., Sato K., Tsuda M., Chikamari K., Mori H., Saito S. Alterations in the levels of β-endorphin-like immunoreactivity in plasma and tissues of obese rats with hypothalamic lesions. Horm. Metab. Res. 16: 105, 1984.

    Article  PubMed  CAS  Google Scholar 

  66. Hershon K.S., Bierman E.L., Bruzzone C.M. Insulin responses to glucose in non-insulin dependent diabetic subjects with and without the chlorpropamide alcohol flush: effect of salicylate and naloxone. Diabetes Care 5: 404, 1982.

    Article  PubMed  CAS  Google Scholar 

  67. Giugliano D. Acetylsalicylic acid in diabetes. Lancet 1: 560, 1981.

    Article  PubMed  CAS  Google Scholar 

  68. Giugliano D., Ceriello A., Saccomanno F., Quatraro A., Paolisso G., D’Onofrio F. Effects of salicylate, tolbutamide and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 61: 160, 1985.

    Article  PubMed  CAS  Google Scholar 

  69. Giugliano D., Torella R.; Improta L. Effects of prostaglandin E1 and prostaglandins F2a on insulin and glucagon plasma levels during the intravenous glucose tolerance test in man. Diabete Metab. 4: 187, 1978.

    PubMed  CAS  Google Scholar 

  70. Giugliano D., Di Pinto P., Ceriello A., Saccomanno F., Passariello N., D’Onofrio F. Impaired insulin secretion in human diabetes mellitus. Interactions between naloxone, phentolamine and lysine acetylsalicylate upon glucose induced insulin release. Diabete Metab. 11: 350, 1985.

    PubMed  CAS  Google Scholar 

  71. Boufoux P.M., Grossman A., Lytras N., Besser G.M. Evidence for the participation of endogenous opioids in the sympathoadrenal response to hypoglycaemia in man. Clin. Endocrinol. (Oxf.) 22: 49, 1985.

    Article  Google Scholar 

  72. Schusdziarra V., Henrichs I., Holland A., Klier M., Pfeiffer E.F. Evidence for an effect of exorphins on plasma insulin and glucagon levels in dogs. Diabetes 30: 362, 1981.

    Article  PubMed  CAS  Google Scholar 

  73. Schusdziarra V., Schick R., De la Fuente A., Holland A., Brantl V., Pfeiffer E.F. Effect of β-casomorphins on somatostatin release in dogs. Endocrinology 112: 1948, 1983.

    Article  PubMed  CAS  Google Scholar 

  74. Brantl V., Teschemacher H., Henschen A. Novel opioid peptides derived from casein (β-casomorphin). Hoppe Seylers Z. Physiol. Chem. 360: 1211, 1979.

    Article  PubMed  CAS  Google Scholar 

  75. Schusdziarra V., Holland A., Schick R., De la Fuente A., Klier M., Maier V., Brantl V., Pfeiffer E.F. Modulation of post-prandial insulin release by ingested opiate-like substances in dogs. Diabetologia 24: 113, 1983.

    Article  PubMed  CAS  Google Scholar 

  76. Morley J.E., Levine A.S., Yamada T., Gebhard R.L., Prigge F., Shafer R.B., Goetz F.C., Silvis S.E. Effect of exorphins on gastrointestinal function, hormonal release, and appetite. Gastroenterology 84: 1517, 1983.

    PubMed  CAS  Google Scholar 

  77. Giugliano D., Ceriello A., Quatraro A., D’Onofrio F. Endogenous opiates, heroin addiction, and non-insulin-dependent diabetes. Lancet 2: 769, 1985.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. I Cattedra di Endocrinologia, II Clinica Medica, Università di Roma “La Sapienza”, V.le del Policlinico 100, 00161, Roma, Italy

    A. Lala & G. Tamburrano

  2. Department of Endocrinology, St. Bartholomew’s Hospital, 59 Bartholomew’s Close, London EC1, UK

    P. Bouloux

  3. Department of Diabetes and Immunogenetics, St. Bartholomew’s Hospital, 59 Bartholomew’s Close, London EC1, UK

    E. Gale

Authors
  1. A. Lala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Bouloux
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Tamburrano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Gale
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lala, A., Bouloux, P., Tamburrano, G. et al. Opioid peptides and glucose metabolism. J Endocrinol Invest 10, 95–104 (1987). https://doi.org/10.1007/BF03347164

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347164

Key-words

Search

Navigation